All filters
Slidesets
Will DAA drug-drug interactions matter in the future - David Back, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Viral hepatitis and pregnancy - Eleni Nastouli
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Cost per cure-is it worth it? - Douglas Dieterich, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Towards more affordable HCV therapy - Andrew Hill, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Management of HCV: Pre and Post transplant - Kosh Agarwal, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
ESLD and its complications - Massimo Puoti, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Immunology and the pathophysiology of liver disease in coinfection - Raymond Chung, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
NASH, what is it, who gets it and what are the implication for the HIV patient - Emmanouil Tsochatzis, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
HBV - Current and Future Treatment paradigms - Patrick Kennedy, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Viral Hepatitis and Malignancy - David Pinato, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Delta Hepatitis-New approaches to therapy - Vincent Soriano, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
26_Dieterich
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Recreational drug use in the HIV population - David Stuart
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Debate: HIV is no special population anymore - Sanjay Bhagani, BSc, FRCP
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Clinical Relevant Drug Interactions - Saye Khoo, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Transmission of (primary) Drug resistance - Charles Boucher, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Translation to Clinical Management - Jonathan Schapiro, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015
Slidesets
Treatment Failure and PI Monotherapy - Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2015
Slidesets
Longterm Complications of HIV Treatment - Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2015
Slidesets
Treatment Failure and PI Monotherapy - Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2015
Slidesets
Longterm Complications of HIV Treatment - Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2015
Slidesets
Second-line ART in Resource Limited Settings - Nicholas Paton, MD, FRCP
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2015
Slidesets
Second-line ART in Resource Limited Settings - Nicholas Paton, MD, FRCP
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2015